In a week that has seen a Global Talent visa launched, the ABPI has welcomed the Government’s ambition to build a future immigration system which supports the UK’s thriving life sciences sector.
The DHSC has announced a consultation into the Statutory Scheme. This looks at amending the payment percentages in the Branded Health Service Medicines (Costs) Regulations 2018.
Novartis has announced a collaboration with NHS England, the National Institute for Health Research and Oxford University.
The ABPI has welcomed the news that the Conservative Party have won a majority and looks forward to working with the new Government.
The Northern Ireland Department of Health has announced that Northern Ireland (NI) patients will have the same access to new cancer medicines as patients in England.
The Government has announced further details for how they will support pharmaceutical companies’ investments in the development of drugs that will treat AMR infections.
A new survey by the Association of the British Pharmaceutical Industry (ABPI) into links between industry and academia shows a significant rise in the number of higher level apprenticeships across the pharmaceutical industry over the past four years.
The NHS Confederation and the ABPI have today published a new report to help the NHS and life sciences industry work more closely together.
King’s College London, Wellcome and pharmaceutical company MSD announced a collaboration and licencing deal today that could lead to a new class of pain medications.